Health-tech startups need patience; deep-tech’s in favour now: Endiya Partners' Ramesh Byrapaneni

Indian Healthcare needs to embrace Technology: COVID the 'force multiplier'

In the current scenario of COVID-19 pandemic, all businesses need to pause, see the big picture, envision the future, align their vision and mission statements with the opportunities that would open up, prioritize and finally press the reset button.

Lifesciences 2.0: Genomics

We well understand that genome is the key to understanding an individual at the cellular level along with his or her characteristics, idiosyncrasies and above all medical conditions or the susceptibility to one. If the genes hold the key to an individual’s traits there must be deep information available in them about why and how diseases affect the individual and whether there exists a pattern in the genes of various people who are susceptible to a specific medical condition.